STARTUP PROFILE

SynchNeuro

COUNTRY
USA
FOUNDED
2021
CATEGORY
Diagnostics and Assessment
Providing a behind-the-ear EEG wearable that non-invasively predicts blood glucose, sleep quality, and metabolic health via brain-signal analysis.
Visit website →
Neurofounders Insights
$   Funding   -
Seed
MODALITY
EEG
FORM FACTOR
Earbud/headphone
INTERFACE DEPTH
Non-invasive
INDICATION
Other
TARGET USER
Patients
REGULATORY STAGE
Preclinical
SynchNeuro is taking an unconventional approach by using behind-the-ear EEG to infer metabolic and physiological states such as blood glucose and sleep quality. This is an ambitious cross-domain biomarker thesis, though one that will require unusually strong validation to gain trust.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
SynchNeuro
No items found.